|
|
María Salazar, Arkaitz Carracedo, Íñigo J. Salanueva, Sonia Hernández-Tiedra, Mar Lorente, Ainara Egia, Patricia Vázquez, Cristina Blázquez, Sofía Torres, Stephane García, Jonathan Nowak, Gian María Fimia, Mauro Piacentini, Francesco Cecconi, Pier Paolo Pandolfi, Luis González-Feria, Juan L. Iovanna, Manuel Guzmán, Patricia Boya, Guillermo Velasco
J Clin Invest. 2009;
119(5):1359
doi:10.1172/JCI37948
Abstract |
Full text
| PDF
| Supplemental material

A
utophagy can promote cell survival or cell death, but the molecular basis underlying
its dual role in cancer remains obscure. Here we demonstrate that
Δ9-tetrahydrocannabinol (THC), the main active component of
marijuana, induces human glioma cell death through stimulation of autophagy. Our data
indicate that THC induced ceramide accumulation and eukaryotic translation initiation
factor 2α (eIF2α) phosphorylation and thereby activated an ER
stress response that promoted autophagy via tribbles homolog 3–dependent
(TRB3-dependent) inhibition of the Akt/mammalian target of rapamycin complex 1
(mTORC1) axis. We also showed that autophagy is upstream of apoptosis in
cannabinoid-induced human and mouse cancer cell death and that activation of this
pathway was necessary for the antitumor action of cannabinoids in vivo. These
findings describe a mechanism by which THC can promote the autophagic death of human
and mouse cancer cells and provide evidence that cannabinoid administration may be an
effective therapeutic strategy for targeting human cancers.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(64)
| Title and authors |
Publication |
Year |
Autophagy in Brain Tumors: A New Target for Therapeutic Intervention : Modulating Autophagy in Brain Tumors
Niroop Kaza, Latika Kohli, Kevin A. Roth
|
Brain Pathology
|
2012 |
Autophagy in Pancreatic Cancer
Daniel Grasso, Maria Noé Garcia, Juan L. Iovanna
|
International Journal of Cell Biology
|
2012 |
Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
Maja Misirkic, Kristina Janjetovic, Ljubica Vucicevic, Gordana Tovilovic, Biljana Ristic, Urosh Vilimanovich, Ljubica Harhaji-Trajkovic, Mirjana Sumarac-Dumanovic, Dragan Micic, Vladimir Bumbasirevic
|
Pharmacological Research
|
2012 |
E Platinum, a newly synthesized platinum compound, induces autophagy via inhibiting phosphorylation of mTOR in gastric carcinoma BGC-823 cells
Chen Hu, Mei-Juan Zou, Li Zhao, Na Lu, Ya-Jing Sun, Shao-Hua Gou, Tao Xi, Qing-Long Guo
|
Toxicology Letters
|
2012 |
Plus ça change, plus c’est la même chose
Laurence A. Turka
|
J. Clin. Invest.
|
2012 |
Ceramide as a target of chemotherapy: its role in apoptosis and autophagy
Clara De Palma, Cristiana Perrotta
|
Clinical Lipidology
|
2012 |
Stress management at the ER: Regulators of ER stress-induced apoptosis
Adrienne M. Gorman, Sandra J.M. Healy, Richard Jäger, Afshin Samali
|
Pharmacology & Therapeutics
|
2012 |
Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
Jie Liu, Liang Zhou, Keming Xiong, Grzegorz Godlewski, Bani Mukhopadhyay, Joseph Tam, Shi Yin, Peter Gao, Xin Shan, James Pickel
|
Gastroenterology
|
2012 |
Autophagy and cancer
Kyeong Sook Choi
|
Exp Mol Med
|
2012 |
TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death
M Seillier, S Peuget, O Gayet, C Gauthier, P N'Guessan, M Monte, A Carrier, J L Iovanna, N J Dusetti
|
Cell Death Differ
|
2012 |
|